Ahead of its debut, shares of Dr. Agarwal’s Health Care were commanding no grey market premium (GMP). Analysts said the muted premium primarily reflects weak market sentiment, along with concerns about its high valuation, lower profitability, and the significant promoter exit via the offer for sale (OFS).
